Difference between revisions of "NM Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
m
m
 
Line 18: Line 18:
 
::* TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee]
 
::* TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee]
 
::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
 
::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
 +
::* PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee]
 +
  
 
==Meetings==
 
==Meetings==
  
 
* Zoom calls are held Quarterly. Please contact RSNA Staff for details.
 
* Zoom calls are held Quarterly. Please contact RSNA Staff for details.

Latest revision as of 22:59, 17 May 2022

Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
RSNA Staff Support: Julie Lisiecki


Scope

The NM Coordinating Committee is responsible for:

  • Monitoring and coordinating the activities of NM Biomarker Committees
  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the NM Biomarker Committees


Meetings

  • Zoom calls are held Quarterly. Please contact RSNA Staff for details.